TrumpRX: Medicare’s New Weight Loss Coke—Now in Pill Form!
In a twist messier than a TikTok diet challenge, the Trump administration is creeping towards a pharma bromance with Eli Lilly and Novo Nordisk to make weight loss drugs like Wegovy and Zepbound cheaper and Medicare-eligible. Imagine Wegovy dropping to $149/month on TrumpRX (official whitehouse-tool-for-shedding-bills) while Zepbound flexes at $299. Oh, and remember the April 2025 sabotage of Biden’s $40B idea to cover these magic needles? Yeah, now Trump’s shopping that buffet again, aiming to cover these drugs for both Medicare and possibly Medicaid users. Half of obese seniors were already halfway in before this saga even began.
Share the Story
(1 of 3)Trump's Medicare deal lets seniors lose weight for less while confusing the internet about who really hates spending big on drugs. Meanwhile, Wegovy and Zepbound are like the overpriced avocado toast of pharmaceuticals – now 'affordable' at hundreds a month!
Medicare covering weight loss drugs finally proves the government cares about more than just Twitter polls and obscure middle names.
Drug companies dropping prices on weight loss meds after politics does the math feels like your diet: inconsistent, overpriced, but somehow still hopeful.
Source: Axios | Published: 11/4/2025 | Author: Caitlin Owens
More Articles in Health
Army Launches 9-1-1 Hotline Because Soldiers Really Love Calling IT
Microsoft Finally Lets Windows 11 Fans Stop Pretending to Use ViVeTool
Epstein Survivors Declare 'Done' While Melania Passes the Buck Faster Than a Baton
Telehealth Startup Outsources Doctors to AI and Angolan Phone Lines
Widow Turns Frozen Sperm Time Capsule Into Baby After 10-Year Hiatus
OpenAI CEO Temporarily Downgrades from AI Overlord to Human POTS Patient
Woman Quits Job at 38 to Audit Diaper Changing as Full-Time Gig
Utah Lets Robot Shrink Prescribe Meds, Because What Could Go Wrong?
